Literature DB >> 16804854

Dideoxynucleoside analogues should be used cautiously in patients with hepatic steatosis.

Marija Zeremski, Andrew H Talal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16804854     DOI： 10.1086/505501

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Nonalcoholic fatty liver disease among HIV-infected persons.

Authors:  Nancy Crum-Cianflone; Angelica Dilay; Gary Collins; Dean Asher; Richard Campin; Sheila Medina; Zach Goodman; Robin Parker; Alan Lifson; Thomas Capozza; Mary Bavaro; Braden Hale; Charles Hames
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

2.  Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir.

Authors:  V Borghi; L Bisi; L Manzini; A Cossarizza; C Mussini
Journal:  Infection       Date:  2012-12-09       Impact factor: 3.553

3.  Traditional but not HIV-related factors are associated with nonalcoholic fatty liver disease in Asian patients with HIV-1 infection.

Authors:  Takeshi Nishijima; Hiroyuki Gatanaga; Takuro Shimbo; Hirokazu Komatsu; Yuichi Nozaki; Naoyoshi Nagata; Yoshimi Kikuchi; Mikio Yanase; Shinichi Oka
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.